A study of 1173 human patients with mild or overt DCM confirmed the reliability of NT-proBNP as a general marker of DCM, but demonstrated that its ability to act as a prognostic biomarker was weak in early stages of the disease [152]. Here, NPPB is linked to familial dilated cardiomyopathy.